BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35992141)

  • 1. Identification of the alpha linolenic acid metabolism-related signature associated with prognosis and the immune microenvironment in nasopharyngeal carcinoma.
    Fang Z; Huang H; Wang L; Lin Z
    Front Endocrinol (Lausanne); 2022; 13():968984. PubMed ID: 35992141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of tumor-infiltrating immune cells and microenvironment-relevant genes in nasopharyngeal carcinoma based on gene expression profiling.
    Zou Z; Ha Y; Liu S; Huang B
    Life Sci; 2020 Dec; 263():118620. PubMed ID: 33096113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of markers for predicting prognosis and endocrine metabolism in nasopharyngeal carcinoma by miRNA-mRNA network mining and machine learning.
    Zhang X; Li X; Wang C; Wang S; Zhuang Y; Liu B; Lian X
    Front Endocrinol (Lausanne); 2023; 14():1174911. PubMed ID: 37538797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell Proliferation and Apoptosis-Related Genes Affect the Development of Human Nasopharyngeal Carcinoma Through PI3K/AKT Signaling Pathway.
    Li W; Ma H; Liu M
    Mol Biotechnol; 2021 Nov; 63(11):1081-1091. PubMed ID: 34236626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunocyte infiltration characteristics of gene expression profile in nasopharyngeal carcinoma and clinical significance].
    Yang Y; Zhang P; Zhang H; Lu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Dec; 36(12):1069-1075. PubMed ID: 33325359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of spatial heterogeneity of tumor microenvironment in nasopharyngeal carcinoma via transcriptional digital spatial profiling.
    Wang L; Wang D; Zeng X; Zhang Q; Wu H; Liu J; Wang Y; Liu G; Pan Y
    Int J Biol Sci; 2023; 19(7):2256-2269. PubMed ID: 37151882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immune-related prognostic model predicts neoplasm-immunity interactions for metastatic nasopharyngeal carcinoma.
    Chen X; Ding Q; Lin T; Sun Y; Huang Z; Li Y; Hong W; Chen X; Wang D; Qiu S
    Front Immunol; 2023; 14():1109503. PubMed ID: 37063853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation biomarkers for nasopharyngeal carcinoma.
    Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
    PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acylglycerol kinase promotes the stemness of nasopharyngeal carcinoma cells by promoting β-catenin translocation to the nucleus through activating PI3K/Akt pathway.
    Zhao Q; Sun P; Qin S; Liu J
    Environ Toxicol; 2020 Dec; 35(12):1299-1307. PubMed ID: 32652857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma.
    Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Li W; Fu Z
    World J Surg Oncol; 2019 Apr; 17(1):60. PubMed ID: 30935420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell-derived exosome RNF126 affects the immune microenvironment and promotes nasopharyngeal carcinoma progression by regulating PTEN ubiquitination.
    Yu C; Xue B; Li J; Zhang Q
    Apoptosis; 2022 Aug; 27(7-8):590-605. PubMed ID: 35717659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3K-PKB-mTOR hyperactivation in relation to nasopharyngeal carcinoma progression and prognosis.
    Yu JH; Chen L; Yu JY; Luo HQ; Wang L
    J Cell Biochem; 2019 Jun; 120(6):10186-10194. PubMed ID: 30582216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
    Huang Q; Hou S; Zhu X; Liu S
    World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key genes affecting the progression of nasopharyngeal carcinoma identified by RNA-sequencing and bioinformatic analysis.
    Wang Y; Li M; Guo Y; Huang H; Dong X; Sun Y; Liu J
    Aging (Albany NY); 2021 Sep; 13(18):22176-22187. PubMed ID: 34544905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngeal carcinoma.
    Tang S; Wu Z; Chen L; She L; Zuo W; Luo W; Zhang Y; Liang S; Liu G; He B; He J; Zhang N
    Front Immunol; 2023; 14():1258344. PubMed ID: 37744335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA ZFAS1 promotes proliferation and migration and inhibits apoptosis in nasopharyngeal carcinoma via the PI3K/AKT pathway in vitro.
    Wang X; Jin Q; Wang X; Chen W; Cai Z
    Cancer Biomark; 2019; 26(2):171-182. PubMed ID: 31403940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway.
    Xie X; Xiong G; Chen W; Fu H; Li M; Cui X
    Biochem Cell Biol; 2020 Dec; 98(6):653-660. PubMed ID: 32459973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of candidate genes of nasopharyngeal carcinoma by bioinformatical analysis.
    Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Fu Z
    Arch Oral Biol; 2019 Oct; 106():104478. PubMed ID: 31319350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.
    Xie Z; Li W; Ai J; Xie J; Zhang X
    J Transl Med; 2022 Jun; 20(1):264. PubMed ID: 35676661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.